An Italian Cost-effectiveness Analysis of Paclitaxel Albumin (nab Paclitaxel) Vs Solvent-based Paclitaxel for Metastatic Breast Cancer Patients - the CONSTANZA Study

被引：0
|
作者：
Lazzaro, C. [1 ]
Bordonaro, R. [2 ]
Cognetti, F. [3 ]
Fabi, A. [3 ]
De Placido, S. [4 ]
Arpino, G. [4 ]
Marchetti, P. [5 ]
Botticelli, A. [5 ]
Pronzato, P. [6 ]
Martelli, E. [7 ]
机构：
[1] Hlth Econ Res & Consulting, Studio Econ Sanit, Milan, Italy
[2] Publ Hosp Trust Garibaldi, Dept Med Oncol, Catania, Italy
[3] Regina Elena Inst Canc Res, Dept Med Oncol A, Rome, Italy
[4] Federico II Univ Hosp, Sch Med, Dept Endocrinol & Mol & Clin Oncol, Naples, Italy
[5] Publ Hosp Trust StAndrea, Dept Med Oncol, Rome, Italy
[6] Natl Canc Res Inst, Dept Med Oncol A, Genoa, Italy
[7] Celgene Srl, Hlth Econ, Milan, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2012年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [1] An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) versus conventional paclitaxel for metastatic breast cancer patients: the COSTANza study
    Lazzaro, Carlo
    Bordonaro, Roberto
    Cognetti, Francesco
    Fabi, Alessandra
    De Placido, Sabino
    Arpino, Grazia
    Marchetti, Paolo
    Botticelli, Andrea
    Pronzato, Paolo
    Martelli, Elisa
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 125 - 135
  • [2] THE COST-EFFECTIVENESS OF NANOPARTICLE ALBUMIN-BOUND PACLITAXEL COMPARED TO SOLVENT-BASED PACLITAXEL IN WOMEN WITH METASTATIC BREAST CANCER
    Vandewalle, B.
    Almeida, J.
    Felix, J.
    Silva, M. J.
    Luz, R.
    VALUE IN HEALTH, 2011, 14 (07) : A451 - A451
  • [3] An Italian Cost-Effectiveness Analysis of Paclitaxel Albumin (nab®-paclitaxel) plus Gemcitabine vs Gemcibatine alone for Metastatic Pancreatic Cancer Patients: The APICE Study
    Lazzaro, C.
    Barone, C.
    Caprioni, F.
    Cascinu, S.
    Falcone, A.
    Maiello, E.
    Milella, M.
    Pinto, C.
    Reni, M.
    Tortora, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [4] An Italian cost-effectiveness analysis of paclitaxel albumin (nab®-paclitaxel) plus gemcitabine vs gemcibatine alone for metastatic pancreatic cancer patients: The APICE study
    Lazzaro, C.
    Barone, C.
    Caprioni, F.
    Cascinu, S.
    Falcone, A.
    Maiello, E.
    Milella, M.
    Pinto, C.
    Reni, M.
    Tortora, G.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] An Italian cost-effectiveness analysis of paclitaxel albumin (nab-paclitaxel) plus gemcitabine vs gemcitabine alone for metastatic pancreatic cancer patients: the APICE study
    Lazzaro, Carlo
    Barone, Carlo
    Caprioni, Francesco
    Cascinu, Stefano
    Falcone, Alfredo
    Maiello, Evaristo
    Milella, Michele
    Pinto, Carmine
    Reni, Michele
    Tortora, Giampaolo
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2018, 18 (04) : 435 - 446
  • [6] Cost-effectiveness of nanoparticle albumin-bound (nab) paclitaxel (ABX) vs Cremophor-based paclitaxel (CP) in the treatment of metastatic breast cancer (MBC).
    Gradishar, W
    Wolinsky, S
    Vishalpura, T
    Nightengale, B
    Bramley, T
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 36S - 36S
  • [7] Retrospective analysis of patients with poor prognostic factors and metastatic breast cancer in a phase III study comparing nab-paclitaxel to solvent-based paclitaxel
    Camburn, T.
    Tjulandin, S.
    Davidson, N.
    O'Shaughnessy, J.
    Bhar, P.
    Gradishar, W.
    EJC SUPPLEMENTS, 2008, 6 (07): : 180 - 180
  • [8] Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective
    Dranitsaris, George
    Yu, Bo
    King, Jennifer
    Kaura, Satyin
    Zhang, Adams
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 249 - 256
  • [9] A UK COST-UTILITY ANALYSIS OF PACLITAXEL ALBUMIN COMPARED TO SOLVENT-BASED PACLITAXEL MONOTHERAPY AND DOCETAXEL MONOTHERAPY FOR PRETREATED METASTATIC BREAST CANCER (MBC)
    McLeod, E. J.
    Lloyd, A.
    Samyshkin, Y.
    Prunieras, F.
    Canney, P.
    VALUE IN HEALTH, 2010, 13 (07) : A269 - A269
  • [10] Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
    Gardner, Erin R.
    Dahut, William L.
    Scripture, Charity D.
    Jones, Jacquin
    Aragon-Ching, Jeanny B.
    Desai, Neil
    Hawkins, Michael J.
    Sparreboom, Alex
    Figg, William D.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4200 - 4205
12345